- Fund Type: Open-End Fund
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: U.S.
Franklin Strategic Series - Franklin Biotechnology Discovery Fund
+ Add to WatchlistFBDIX:US
108.22 USD 1.27 1.16%As of 09:29:30 ET on 05/20/2013.
Snapshot for Franklin Strategic Series - Franklin Biotechnology Discovery Fund (FBDIX)
| Year To Date: | +30.10% | 3-Month: | +18.78% | 3-Year: | +29.41% | 52-Week Range: | 73.62 - 112.26 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +2.50% | 1-Year: | +47.38% | 5-Year: | +17.69% | Beta vs SPX: | 0.96 |
Fund Profile & Information for FBDIX
Franklin Biotechnology Discovery Fund is an open-end fund incorporated in the USA. The Fund's objective is capital appreciation. The Fund invests at least 80% of its net assets in securities of biotechnology companies and discovery research firms. The Fund invests a substantial portion of its assets in equity securities of smaller capitalization companies.
| Inception Date: | 09-15-1997 | Telephone: | 1-800-632-2301 |
|---|---|---|---|
| Managers: | EVAN MCCULLOCH | ||
| Web Site: | www.franklintempleton.com | ||
Fundamentals for FBDIX
| NAV | (on 2013-05-20) 108.22 |
|---|---|
| Assets (M) | (on 2013-04-30) 653.79 |
| Fund Leveraged | N |
| Minimum Investment | 0.00 |
| Minimum Subsequent Investment | - |
Dividends for FBDIX
| Dividend Type | Income |
|---|---|
| Dividend Frequency | Annual |
| Last Dividend Net | (on 2012-12-17) 0.07 |
| Dividend Yield (ttm) | 0.06 |
Fees & Expenses for FBDIX
| Front Load | 5.75 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 0.52 |
| Redemption Fee | 0.00 |
| 12b1 Fee | 0.29 |
| Expense Ratio | 1.26 |
Top Fund Holdings for FBDIX
Filing Date: 03/28/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Gilead Sciences Inc | 1,301,000 | 63,657,930 | 10.428% |
| Celgene Corp | 495,200 | 57,398,632 | 9.402% |
| Biogen Idec Inc | 202,361 | 39,037,461 | 6.395% |
| Amgen Inc | 358,200 | 36,719,082 | 6.015% |
| Alexion Pharmaceuticals Inc | 246,700 | 22,730,938 | 3.723% |
| Vertex Pharmaceuticals Inc | 394,300 | 21,678,614 | 3.551% |
| Medivation Inc | 346,200 | 16,191,774 | 2.652% |
| Ariad Pharmaceuticals Inc | 796,700 | 14,412,303 | 2.361% |
| BioMarin Pharmaceutical Inc | 209,656 | 13,053,183 | 2.138% |
| Pharmacyclics Inc | 151,600 | 12,190,156 | 1.997% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page